Gabelli & Co Investment Advisers’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-106,097	Closed	-$1.98M	–	542
2022 Q1	$1.98M	Buy	106,097 +33,700	+47%	+$606K	0.26%	69
2021 Q4	$1.55M	Buy	+72,397	New	+$1.43M	0.21%	81

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Gabelli & Co Investment Advisers's OCDX Position: Q2 2022 in Review

Gabelli & Co Investment Advisers sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 106,097 shares — an estimated $1.98M sold.

Gabelli & Co Investment Advisers first reported a position in OCDX in Q4 2021 and held it in 2 quarters. The position peaked at $1.98M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Gabelli & Co Investment Advisers reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 106,097 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $1.98M.
Gabelli & Co Investment Advisers first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q4 2021 and held it in 2 quarters.
Gabelli & Co Investment Advisers's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.98M in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2022, filed 12 Aug 2022.